159 related articles for article (PubMed ID: 25129079)
21. NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network.
Oncology (Williston Park); 1998 Nov; 12(11A):396-412. PubMed ID: 10028523
[No Abstract] [Full Text] [Related]
22. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines.
Poonacha TK; Go RS
J Clin Oncol; 2011 Jan; 29(2):186-91. PubMed ID: 21149653
[TBL] [Abstract][Full Text] [Related]
23. Aim of the working group on the Asian perspectives on cancer control: Asian perspective on prostate cancer prevention.
Akaza H
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i2-6. PubMed ID: 20870916
[TBL] [Abstract][Full Text] [Related]
24. NCCN breast cancer clinical practice guidelines in oncology: an update.
Carlson RW
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S61-3. PubMed ID: 19795577
[TBL] [Abstract][Full Text] [Related]
25. Screening for psychosocial distress: a national survey of oncologists.
Pirl WF; Muriel A; Hwang V; Kornblith A; Greer J; Donelan K; Greenberg DB; Temel J; Schapira L
J Support Oncol; 2007; 5(10):499-504. PubMed ID: 18240673
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer working group report.
Saijo N; Fukuoka M; Thongprasert S; Ichinose Y; Mitsudomi T; Mok TS; Ohe Y; Park K; Wu YL
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i7-12. PubMed ID: 20870923
[TBL] [Abstract][Full Text] [Related]
27. Category of evidence and consensus underlying National Comprehensive Cancer Network guidelines: Is there evidence of progress?
Desai AP; Go RS; Poonacha TK
Int J Cancer; 2021 Jan; 148(2):429-436. PubMed ID: 32674225
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer early detection clinical practice guidelines in oncology.
Babaian RJ; Partin AW;
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S42-55. PubMed ID: 19795575
[TBL] [Abstract][Full Text] [Related]
29. Preliminary report: the development of the NCCN Comparative Therapeutic Index™ as a clinical evaluative process for existing data in oncology.
Li EC; DeMartino J
J Natl Compr Canc Netw; 2010 Aug; 8 Suppl 5():S1-9. PubMed ID: 20870621
[TBL] [Abstract][Full Text] [Related]
30. The NCCN/American Cancer Society partnership.
McGivney WT; McGinnis L; Gansler TS;
Oncology (Williston Park); 2000 Nov; 14(11A):213-6. PubMed ID: 11195412
[TBL] [Abstract][Full Text] [Related]
31. Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium.
Birkeland ML; McClure JS
Arch Pathol Lab Med; 2015 May; 139(5):608-11. PubMed ID: 25333835
[TBL] [Abstract][Full Text] [Related]
32. Implementation of national comprehensive cancer network evidence-based guidelines to prevent and treat cancer-related infections.
Wood SK; Payne JK
Clin J Oncol Nurs; 2012 Jun; 16(3):E111-7. PubMed ID: 22641329
[TBL] [Abstract][Full Text] [Related]
33. Prostate Cancer Working Group report.
Namiki M; Akaza H; Lee SE; Song JM; Umbas R; Zhou L; Lee BC; Cheng C; Chung MK; Fukagai T; Hinotsu S; Horie S
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i70-75. PubMed ID: 20870924
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of preliminary NCCN guidelines by external review.
Winn RJ; Botnick W; Bitsura JA
Oncology (Williston Park); 1996 Nov; 10(11 Suppl):311-5. PubMed ID: 8953611
[TBL] [Abstract][Full Text] [Related]
35. NCCN Practice Guidelines for Prostate Cancer.
Bahnson RR; Hanks GE; Huben RP; Kantoff P; Kozlowski JM; Kuettel M; Lange PH; Logothetis C; Pow-Sang JM; Roach M; Sandler H; Scardino PT; Taylor RJ; Urban DA; Walsh PC; Wilson TG;
Oncology (Williston Park); 2000 Nov; 14(11A):111-9. PubMed ID: 11195405
[TBL] [Abstract][Full Text] [Related]
36. National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important?
Pluchino LA; D'Amico TA
Ann Thorac Surg; 2020 Dec; 110(6):1789-1795. PubMed ID: 32298647
[TBL] [Abstract][Full Text] [Related]
37. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
[No Abstract] [Full Text] [Related]
38. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.
Kanesvaran R; Castro E; Wong A; Fizazi K; Chua MLK; Zhu Y; Malhotra H; Miura Y; Lee JL; Chong FLT; Pu YS; Yen CC; Saad M; Lee HJ; Kitamura H; Prabhash K; Zou Q; Curigliano G; Poon E; Choo SP; Peters S; Lim E; Yoshino T; Pentheroudakis G
ESMO Open; 2022 Aug; 7(4):100518. PubMed ID: 35797737
[TBL] [Abstract][Full Text] [Related]
39. International adaptations of NCCN Clinical Practice Guidelines in Oncology.
Carlson RW; Larsen JK; McClure J; Fitzgerald CL; Venook AP; Benson AB; Anderson BO
J Natl Compr Canc Netw; 2014 May; 12(5):643-8. PubMed ID: 24812133
[TBL] [Abstract][Full Text] [Related]
40. The NCCN Guideline Program: a conceptual framework.
Winn RJ; Botnick WZ
Oncology (Williston Park); 1997 Nov; 11(11A):25-32. PubMed ID: 9430176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
